The Induction Method We Use Because It’s Easy, Not Because It’s Safe
Misoprostol (aka "Cytotec") causes uterine tachysystole in one out of every three inductions. We use it anyway for labor induction because it requires less supervison.
When I joined my institution 25 years ago, misoprostol (”Cytotec”) was the default for labor induction.
For those unfamiliar, misoprostol is a synthetic prostaglandin E1 analog - a medication that causes the cervix to soften and the uterus to contract.
It’s FDA-approved for preventing gastric ulcers in patients taking NSAIDs like ibuprofen. It’s not FDA-approved for labor induction, cervical ripening, or any obstetric use whatsoever, yet it became one of the most commonly used drugs in labor and delivery.
Twenty-five micrograms (sometimes 50) vaginally every four hours. Simple. Efficient. No IV pump to program, no continuous rate adjustments, no nurse tied to the bedside watching an oxytocin drip.
Just drop the tablet in the vagina, document it, and come back in four hours.
Just drop the tablet in the vagina, document it, and come back in four hours.
Then I looked at our cesarean section logs. Tachysystole in 34% of inductions PubMed. Nonreassuring fetal heart tracings requiring urgent delivery. Emergency sections at 2 AM for Category 2 and 3 tracings that developed after the second or third dose of misoprostol.
We stopped using misoprostol.
Our cesarean rate for induction dropped.
Our emergency cesarean rate dropped more. Our NICU admission rate for term babies dropped too.
Our neonatologist even complained that he was losing money because admissions had dropped.
Here’s why that happened.
The Safety Profile Nobody Discusses
When you compare vaginal misoprostol to other induction methods, the incidents of uterine hyperstimulation and tachysystole are significantly higher with misoprostol PubMed. Not marginally higher. Significantly higher.
The numbers: Tachysystole occurs in 24.3% of misoprostol inductions Springer. That’s nearly one in four. In one randomized trial comparing misoprostol to oxytocin, tachysystole occurred in 34.4% of the misoprostol group versus 13.8% in the oxytocin group PubMed.
Think about that. When you choose misoprostol, you’re tripling the risk of tachysystole.
The Number: In studies comparing misoprostol directly to Foley balloon catheters, uterine hyperstimulation was more common with misoprostol, though vaginal delivery rates were higher PubMed Central.
We’re trading safety for speed.
Why Do We Keep Using It?
Because it’s convenient.
From an economic standpoint, misoprostol is inexpensive compared with oxytocin and prostaglandin E2 preparations ScienceDirect.
But there’s another reason nobody says out loud: staffing.
Oxytocin requires continuous monitoring. A nurse at the bedside or nearby, watching the tracing, adjusting the rate every 30 minutes based on contraction pattern and fetal heart rate response. It requires attention. It requires personnel.
Misoprostol? Give it every four hours. The nurse can take care of three other patients. An oxytocin infusion can run unsupervised for many hours without a member of staff checking on its rate or effect on uterine contractions PubMed Central. That’s what makes oxytocin dangerous in understaffed settings.
But misoprostol avoids that risk by creating a different one: misoprostol needs to be regularly administered by a trained member of staff, a factor that forces some kind of regular clinical assessment ScienceDirect.
Regular doesn’t mean continuous. And continuous is what you need when 1 in 3 patients will develop tachysystole.
What Happens When You Stop Using Misoprostol
